FDA Voluntary Guidance on Antibiotics Tragically Flawed

For Immediate Release

Contact: 

Phone: 202-332-9110

FDA Voluntary Guidance on Antibiotics Tragically Flawed

Statement of CSPI Food Safety Director Caroline Smith DeWaal

WASHINGTON - The Food and Drug Administration's new policies intended to reduce the overuse of important antibiotics in animal production are tragically flawed. They rely too heavily on the drug industry and animal producers to act voluntarily in the best interest of consumers. Protecting public health is an authority and a responsibility that rests squarely with the FDA.

The announcement at least indicates that the agency recognizes a "public health imperative" to tackle this problem. Decades of misuse have led to some common pathogens, like Salmonella, becoming more virulent and less treatable. The FDA knows it can no longer afford to ignore antibiotic resistance. In March, the agency took a step in the right direction by banning certain extra-label uses of cephalosporin in certain food-producing animals. And last month, a federal court held that the agency must proceed with withdrawal actions on antibiotics. Many of these issues are addressed in the Preservation of Antibiotics in Medical Treatment Act, which the Administration should support. PAMTA would require the FDA to conduct regular reevaluation of drugs used in animal production.

###

Since 1971, the Center for Science in the Public Interest has been a strong advocate for nutrition and health, food safety, alcohol policy, and sound science.

Share This Article

More in: